Primary Human Cells
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
-
- NCTR Acquisition Liaison nctracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new requirement for primary human trophoblast cells to support research conducted by the Perinatal Health Center of Excellence (PHCE). The solicitation is estimated to be released on January 1, 2026, with an anticipated award date of April 1, 2026. This procurement falls under NAICS code 541990 (All Other Professional, Scientific, and Technical Services) and does not utilize any set-aside provisions.
The estimated award value for this contract ranges from $25,000 to $250,000. Interested vendors should direct inquiries to the Food and Drug Administration's Acquisition Liaison at nctracquisitions@fda.hhs.gov. Additional details regarding specific quantities, delivery timelines, and performance location details are not currently available in the forecast.
Forecast text
Primary human trophoblast cells required to support Perinatal Health Center of Excellence (PHCE) funded research.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast